{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:07:13Z","timestamp":1793326033717,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T00:00:00Z","timestamp":1711843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002201","name":"Ministry of Social and Family Development, Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002201","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jctube.2024.100433","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T11:56:22Z","timestamp":1711972582000},"page":"100433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Concomitant bedaquiline and delamanid therapy in patients with drug-resistant extra-pulmonary tuberculosis in Mumbai, India"],"prefix":"10.1016","volume":"35","author":[{"given":"Himani","family":"Mongia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Mamnoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunima","family":"Silsarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpa","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam Arago","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramila","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homa","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinalini","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Isaakidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2024.100433_b0005","unstructured":"World Health Organization. Global tuberculosis report 2020 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240013131 (accessed January 8, 2024)."},{"key":"10.1016\/j.jctube.2024.100433_b0010","unstructured":"Ministry of Health and Family Welfare. Leading the way: India TB Report 2023 2023. https:\/\/tbcindia.gov.in\/showfile.php?lid=3680 (accessed January 8, 2024)."},{"issue":"9","key":"10.1016\/j.jctube.2024.100433_b0015","first-page":"EE01","article-title":"Laboratory diagnosis of extra-pulmonary tuberculosis (EPTB) in resource-constrained setting: state of the art, challenges and the need","author":"Purohit","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jctube.2024.100433_b0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tube.2012.06.003","article-title":"Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects","volume":"92","author":"Kurbatova","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jctube.2024.100433_b0025","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijid.2020.05.087","article-title":"Poor treatment outcome and its predictors among drug-resistant tuberculosis patients in Ethiopia: a systematic review and meta-analysis","volume":"98","author":"Alemu","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jctube.2024.100433_b0030","unstructured":"Ministry of Health and Family Welfare. Report of the First National Anti TB Drug Resistance Survey\u00a0: India 2014-16 2016. https:\/\/tbcindia.gov.in\/showfile.php?lid=3315 (accessed January 8, 2024)."},{"key":"10.1016\/j.jctube.2024.100433_b0035","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/cid\/ciac019","article-title":"Safety of treatment regimens containing bedaquiline and delamanid in the endTB cohort","volume":"75","author":"Hewison","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jctube.2024.100433_b0040","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s40262-022-01133-2","article-title":"Population pharmacokinetics of delamanid and its Main metabolite DM-6705 in drug-resistant tuberculosis patients receiving delamanid alone or coadministered with bedaquiline","volume":"61","author":"Tanneau","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jctube.2024.100433_b0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijtb.2019.02.006","article-title":"Early efficacy and safety of bedaquiline and delamanid given together in a \u201csalvage regimen\u201d for treatment of drug-resistant tuberculosis","volume":"66","author":"Sarin","year":"2019","journal-title":"Indian J Tuberc"},{"key":"10.1016\/j.jctube.2024.100433_b0050","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3201\/eid2310.170834","article-title":"Bedaquiline and delamanid combination treatment of 5 patients with pulmonary extensively drug-resistant tuberculosis","volume":"23","author":"Maryandyshev","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jctube.2024.100433_b0055","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03026-2020","article-title":"Concurrent use of bedaquiline and delamanid for the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis: a nationwide cohort study in South Korea","volume":"57","author":"Kwon","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jctube.2024.100433_b0060","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02550-2017","article-title":"Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia","volume":"51","author":"Guglielmetti","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jctube.2024.100433_b0065","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S1473-3099(18)30100-2","article-title":"Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study","volume":"18","author":"Ferlazzo","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jctube.2024.100433_b0070","doi-asserted-by":"crossref","first-page":"E3496","DOI":"10.1093\/cid\/ciaa1577","article-title":"One step forward: successful end-of-treatment outcomes of patients with drug-resistant tuberculosis who received concomitant bedaquiline and delamanid in Mumbai","volume":"73","author":"Das","year":"2021","journal-title":"India Clin Infect Dis"},{"key":"10.1016\/j.jctube.2024.100433_b0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17425255.2021.1836158","article-title":"Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems","volume":"17","author":"M\u00e4rtson","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jctube.2024.100433_b0080","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00913-19","article-title":"Delamanid central nervous system pharmacokinetics in tuberculous meningitis in rabbits and humans","volume":"63","author":"Tucker","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jctube.2024.100433_b0085","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240063129 (accessed January 8, 2024)."},{"key":"10.1016\/j.jctube.2024.100433_b0090","unstructured":"National TB Elimination Programme. Training modules (1-4) for programme managers & medical officers 2020. https:\/\/tbcindia.gov.in\/WriteReadData\/NTEPTrainingModules1to4.pdf (accessed January 8, 2024)."},{"key":"10.1016\/j.jctube.2024.100433_b0095","unstructured":"World Population by Country 2024 (Live) n.d. https:\/\/worldpopulationreview.com\/ (accessed January 8, 2024)."},{"key":"10.1016\/j.jctube.2024.100433_b0100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11524-018-0319-6","article-title":"The risk of tuberculosis among populations living in slum settings: a systematic review and meta-analysis","volume":"96","author":"Noykhovich","year":"2019","journal-title":"J Urban Health"},{"key":"10.1016\/j.jctube.2024.100433_b0105","first-page":"53","article-title":"Recent changes in guidelines on programmatic management of drug resistant tuberculosis in India 2019: a paradigm shift in tuberculosis control","volume":"8","author":"Chaudhuri","year":"2020","journal-title":"J Assoc Chest Phys"},{"key":"10.1016\/j.jctube.2024.100433_b0110","doi-asserted-by":"crossref","unstructured":"Isaakidis P, Cox HS, Varghese B, Montaldo C, da Silva E, Mansoor H, et al. Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India. PLoS One 2011;6. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0028066.","DOI":"10.1371\/journal.pone.0028066"},{"key":"10.1016\/j.jctube.2024.100433_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234651","article-title":"Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges","volume":"15","author":"Chavan","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jctube.2024.100433_b0120","unstructured":"Clinical and Programmatic Guide for Patient Management with New TB Drugs: Version 4.0 2018. https:\/\/endtb.org\/sites\/default\/files\/2018-04\/Guide%20for%20New%20TB%20Drugs%20Version%204.0.pdf (accessed March 11, 2024)."},{"key":"10.1016\/j.jctube.2024.100433_b0125","article-title":"Nine-month, all-oral regimens for rifampin-resistant tuberculosis","author":"Guglielmetti","year":"2024","journal-title":"MedRxiv"},{"key":"10.1016\/j.jctube.2024.100433_b0130","unstructured":"Definitions and reporting framework for tuberculosis \u2013 2013 revision: updated December 2014 and January 2020 2013. https:\/\/www.who.int\/publications\/i\/item\/9789241505345 (accessed March 1, 2024)."},{"key":"10.1016\/j.jctube.2024.100433_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/lungindia.lungindia_192_18","article-title":"Extrapulmonary drug-resistant tuberculosis at a drug-resistant tuberculosis center, Mumbai: our experience - Hope in the midst of despair!","volume":"36","author":"Desai","year":"2019","journal-title":"Lung India"},{"key":"10.1016\/j.jctube.2024.100433_b0140","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijmyco.2016.09.054","article-title":"Extrapulmonary tuberculosis among females in South Asia\u2014gap analysis","volume":"5","author":"Mehraj","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.jctube.2024.100433_b0145","article-title":"Epidemiology and factors associated with extra-pulmonary tuberculosis in a low-prevalence area","volume":"32","author":"Rolo","year":"2023","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.jctube.2024.100433_b0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5588\/pha.17.0013","article-title":"Unfavourable outcomes among patients with MDR-TB on the standard 24-month regimen in Maharashtra","volume":"7","author":"Suryawanshi","year":"2017","journal-title":"India Public Health Action"},{"key":"10.1016\/j.jctube.2024.100433_b0155","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01030-2018","article-title":"Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review","volume":"53","author":"Law","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jctube.2024.100433_b0160","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01522-2019","article-title":"Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report","volume":"54","author":"Borisov","year":"2019","journal-title":"Eur Respir J"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579424000202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579424000202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:20:25Z","timestamp":1738711225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579424000202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":32,"alternative-id":["S2405579424000202"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2024.100433","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concomitant bedaquiline and delamanid therapy in patients with drug-resistant extra-pulmonary tuberculosis in Mumbai, India","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2024.100433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100433"}}